Where we are
AetherBio is at the pre-seed stage, converting an interdisciplinary research program into a focused product thesis. Current work centers on protocol definition, reproducible signal preparation, interpretable PAD-oriented modeling, and the evidence infrastructure required for controlled pilot studies.
We are not presenting a finished commercial system. The immediate objective is to establish repeatable research performance, validate the workflow with aligned collaborators, and define the narrowest initial use case where the platform creates measurable research value.
What comes next
The next phase includes controlled research partnerships, workflow testing with prospective users, refinement of the reporting interface, and governance review before any limited beta deployment.